country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-187959

Copy Link Print Information

SLC6A19-IN-6

SLC6A19-IN-6 is a B0AT1 (SLC6A19) inhibitor. SLC6A19-IN-6 inhibits sodium-dependent neutral amino acid transport. SLC6A19-IN-6 can be used for research on non-alcoholic steatohepatitis.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 851269-95-9
Formel: C₁₃H₁₈ClNO₂
Molecular Weight:255.74

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

SLC6A19-IN-6 Chemical Structure

CAS. Nr.: 851269-95-9

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- In Vitro
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

SLC6A19-IN-6 is a B0AT1 (SLC6A19) inhibitor. SLC6A19-IN-6 inhibits sodium-dependent neutral amino acid transport. SLC6A19-IN-6 can be used for research on non-alcoholic steatohepatitis^[1].

In Vitro

SLC6A19-IN-6 (Compound E4) (10 mM; 30 min) inhibits human B⁰AT1 in CHO-BC cells with an IC₅₀ of 13.7 µM in the FLIPR membrane potential assay, and acts primarily in a competitive manner^[1].
SLC6A19-IN-6 (6 min) inhibits human B⁰AT1 in CHO-BC cells with an IC₅₀ of 7.7 µM in a radioactive leucine/isoleucine flux assay^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .

Chemical Information

CAS. Nr. 851269-95-9
Molecular Weight 255.74
Formel C₁₃H₁₈ClNO₂
SMILES

O=C(COC1=C(C)C=C(Cl)C=C1C)NC(C)C
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. Yadav A, et al. Novel Chemical Scaffolds to Inhibit the Neutral Amino Acid Transporter BAT1 (SLC6A19), a Potential Target to Treat Metabolic Diseases. Frontiers in pharmacology. 2020;11:140. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen